219 related articles for article (PubMed ID: 1372966)
1. Chromogranin A epitopes: clues from synthetic peptides and peptide mapping.
Gill BM; Barbosa JA; Hogue-Angeletti R; Varki N; O'Connor DT
Neuropeptides; 1992 Feb; 21(2):105-18. PubMed ID: 1372966
[TBL] [Abstract][Full Text] [Related]
2. Chromogranin B: isolation from pheochromocytoma, N-terminal sequence, tissue distribution and secretory vesicle processing.
Gill BM; Barbosa JA; Dinh TQ; Garrod S; O'Connor DT
Regul Pept; 1991 Apr; 33(2):223-35. PubMed ID: 1882087
[TBL] [Abstract][Full Text] [Related]
3. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites.
Metz-Boutigue MH; Garcia-Sablone P; Hogue-Angeletti R; Aunis D
Eur J Biochem; 1993 Oct; 217(1):247-57. PubMed ID: 8223562
[TBL] [Abstract][Full Text] [Related]
4. The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2.
Arden SD; Rutherford NG; Guest PC; Curry WJ; Bailyes EM; Johnston CF; Hutton JC
Biochem J; 1994 Mar; 298 Pt 3(Pt 3):521-8. PubMed ID: 8141763
[TBL] [Abstract][Full Text] [Related]
5. PC12 cells show immunoreactivity to a number of proteins and peptides, including vasostatin.
Cunningham RT; Pogue KM; Curry WJ; Johnston CF; Buchanan KD
Peptides; 1996; 17(8):1297-301. PubMed ID: 8971922
[TBL] [Abstract][Full Text] [Related]
6. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A: secretion of processed products from the stimulated retrogradely perfused bovine adrenal gland.
Helle KB; Marley PD; Angeletti RH; Aunis D; Galindo E; Small DH; Livett BG
J Neuroendocrinol; 1993 Aug; 5(4):413-20. PubMed ID: 7691355
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods.
Stridsberg M; Angeletti RH; Helle KB
J Endocrinol; 2000 Jun; 165(3):703-14. PubMed ID: 10828855
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A: posttranslational modifications in secretory granules.
Barbosa JA; Gill BM; Takiyyuddin MA; O'Connor DT
Endocrinology; 1991 Jan; 128(1):174-90. PubMed ID: 1986917
[TBL] [Abstract][Full Text] [Related]
10. A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245).
Degorce F; Goumon Y; Jacquemart L; Vidaud C; Bellanger L; Pons-Anicet D; Seguin P; Metz-Boutigue MH; Aunis D
Br J Cancer; 1999 Jan; 79(1):65-71. PubMed ID: 10408695
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides.
Taupenot L; Remacle JE; Helle KB; Aunis D; Bader MF
Regul Pept; 1995 Mar; 56(1):71-88. PubMed ID: 7770635
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla.
Watkinson A; Jönsson AC; Davison M; Young J; Lee CM; Moore S; Dockray GJ
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):471-9. PubMed ID: 1710890
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin A peptide-specific antisera and high-performance size exclusion chromatography demonstrate amino-terminal and carboxy-terminal fragments of the native molecule in human cell lines.
Brandt DW; Burton DW; Hogue-Angeletti R; Deftos LJ
Proc Soc Exp Biol Med; 1994 Apr; 205(4):316-20. PubMed ID: 8171054
[TBL] [Abstract][Full Text] [Related]
14. N-terminal proteolytic processing of porcine chromogranin A in parathyroid tissue.
Fasciotto BH; Cohn DV; Gorr SU
Regul Pept; 2002 Jan; 103(1):53-8. PubMed ID: 11738248
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific processing of chromogranin A in endocrine cells of the rat stomach.
Norlén P; Curry WJ; Björkqvist M; Maule A; Cunningham RT; Hogg RB; Harriott P; Johnston CF; Hutton JC; Håkanson R
J Histochem Cytochem; 2001 Jan; 49(1):9-18. PubMed ID: 11118474
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A from bovine adrenal medulla: molecular characterization of glycosylations, phosphorylations, and sequence heterogeneities by mass spectrometry.
Bauer SH; Zhang XY; Van Dongen W; Claeys M; Przybylski M
Anal Biochem; 1999 Oct; 274(1):69-80. PubMed ID: 10527498
[TBL] [Abstract][Full Text] [Related]
17. Selective processing of chromogranin A in the different islet cells in human pancreas.
Portela-Gomes GM; Stridsberg M
J Histochem Cytochem; 2001 Apr; 49(4):483-90. PubMed ID: 11259451
[TBL] [Abstract][Full Text] [Related]
18. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.
Fasciotto BH; Trauss CA; Greeley GH; Cohn DV
Endocrinology; 1993 Aug; 133(2):461-6. PubMed ID: 8344192
[TBL] [Abstract][Full Text] [Related]
19. Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion.
Drees BM; Rouse J; Johnson J; Hamilton JW
Endocrinology; 1991 Dec; 129(6):3381-7. PubMed ID: 1954912
[TBL] [Abstract][Full Text] [Related]
20. A phylogenetic survey of pancreastatin and chromogranin immunoreactivity in chromaffin (TH-, DBH-, and PNMT-immunoreactive) cells of the adrenal organ of vertebrates.
Reinecke M; Maake C
Gen Comp Endocrinol; 1993 May; 90(2):251-65. PubMed ID: 8100544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
